Ecovyst, Inc. (ECVT)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$10.210.00%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · ECVT
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Grow sales to between $1.02 billion and $1.06 billion in 2026, reflecting organic growth and contributions from acquisitions.
Stated as a priority in 2 of last 2 quarters. Revenue grew 42% from $176.1 million in 2025-Q2 to $250.0 million in 2026-Q2. Management raised full-year 2026 sales guidance from $890-$970 million in 2026-Q1 to $1.02-$1.06 billion in 2026-Q2, reflecting delivery and acquisition contributions. The trajectory is delivering.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Materials names rated neutral grew net income 46% of the time over the next year (vs 54% for the rest of the cohort, n=2582).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“The Companys revised 2026 guidance is as follows: Sales of $1,020 million to $1,060 million”
“The Companys revised 2026 guidance is as follows: Sales of $890 million to $970 million (change from $860 million to $940 million)”
Maintain disciplined capital expenditures with guidance raised to $85 million to $95 million for fiscal year 2026.
Capital expenditures guidance has been stated in 3 of last 3 quarters. The guidance increased from $80-$90 million in 2026-Q1 to $85-$95 million in 2026-Q2. This reflects management's continued focus on disciplined capital allocation. The trajectory shows modest upward revision consistent with stated priorities.
“Capital expenditures of $85 million to $95 million”
“Capital expenditures of $80 million to $90 million”
“Capital expenditures of Ecoservices of $60 million to $70 million”
Target adjusted free cash flow between $45 million and $55 million for fiscal year 2026 to support financial flexibility.
Adjusted Free Cash Flow target has been stated in 3 of last 3 quarters. Management raised the low end of the 2026 guidance from $40 million in 2026-Q1 to $45 million in 2026-Q2, maintaining the high end at $55 million. This reflects ongoing focus on cash flow generation. The trajectory is delivering with positive cash flow reported.
“Adjusted Free Cash Flow of $45 million to $55 million”
“Adjusted Free Cash Flow of $40 million to $55 million”
“Adjusted Free Cash Flow of $35 million to $55 million”
Continue to pursue and integrate acquisitions that expand the Companys sulfur-based product platform and market presence.
Management stated this priority in 2 of last 2 quarters. The acquisition of the Calabrian sulfur dioxide business was completed in 2026-Q2, expanding the Company's sulfur-based solutions platform. This acquisition supports management's stated growth strategy. The trajectory shows delivery on acquisition-driven growth.
“In Q2 2026, we completed our acquisition of the Calabrian sulfur dioxide and related derivatives business”
“The year-end divestiture of our Advanced Materials & Catalysts segment provides flexibility to accelerate growth through accretive inorganic opportunities”
Continue the stock repurchase program with $146.5 million available for future share repurchases as of mid-2026.
Management stated this priority in 2 of last 2 quarters. The stock repurchase program had $146.5 million available as of both 2026-Q1 and 2026-Q2. The Company repurchased shares in 2026-Q1 but not in 2026-Q2. The trajectory is consistent with maintaining the program and available capacity.
“$146.5 million was available for stock repurchases under the program”
“$146.5 million was available for stock repurchases under the program”
Over the trailing year it converted 4.01x of net income into operating cash flow. Historically, Materials names rated robust grew net income 56% of the time over the next year (vs 47% for the rest of the cohort, n=1401).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, Fed net liquidity, long-term interest rates, real (inflation-adjusted) rates (low R² over the window).
16 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Materials names rated neutral grew net income 49% of the time over the next year (vs 52% for the rest of the cohort, n=976).
Not investment advice. As of 2026-09-04.